SBNP announcements S&p Custom/bnp Paribas Spectrumus Sect announcements and dividends declared INDICES
S&p Custom/bnp Paribas Spectrumus Sect Complete list of announcements declared & dividend announcements by S&p Custom/bnp Paribas Spectrumus Sect SBNP
S&p Custom/bnp Paribas Spectrumus Sect SBNP listed on INDICES and deals inAnnouncements and dividends declared by S&p Custom/bnp Paribas Spectrumus Sect SBNP
India gets its first data-backed microdrama studio as Pratilipi launches Double Tap Films
Pratilipi has launched Double Tap Films, India's first data-backed microdrama studio. This new venture will create short, vertical videos using insights from Pratilipi's vast story ecosystem. The studio leverages user-validated intellectual property from i
Announcement as on 02 April 2026
Oil could hit 0 if Iran tensions escalate, warns Peter McGuire; here's what happens to gold next
Peter McGuire of Australia-Trading.com highlights how Trump's Iran ultimatum has created market volatility, particularly in oil, gold, and silver. He outlines two oil price scenarios, ranging from -0 to a potential 0-0 per barrel, depending on
Announcement as on 02 April 2026
JLR sales roar back: Jaguar Land Rover posts 61% jump in Q4 as production recovers from cyber setback
Jaguar Land Rover saw a significant 61.1% jump in sales for the fourth quarter. This recovery follows production disruptions from a cyber attack last year. Despite this strong quarter, full-year sales declined due to various global challenges. The popular
Announcement as on 02 April 2026
Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%
Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low prices in the US, raising concerns over costs and supply chains.
Announcement as on 02 April 2026
Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk
The US FDA has approved Eli Lilly's new weight-loss pill, Foundayo. This marks a significant step in the ongoing competition with rival Novo Nordisk in the GLP-1 medicine market. Foundayo is an oral medication offering a new option for weight management. L
Announcement as on 02 April 2026
Announcements by S&p Custom/bnp Paribas Spectrumus Sect first page | Next page | Prev page |
SBNP S&p Custom/bnp Paribas Spectrumus Sect current price & indicator signals
Recent prices of SBNP S&p Custom/bnp Paribas Spectrumus Sect are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 07 Tue Apr 2026 | 6491.13 | 6443.59 to 6500.86 | -0.15% | 0 times |
| 06 Mon Apr 2026 | 6500.84 | 6474.78 to 6503.86 | 0.28% | 0 times |
| 02 Thu Apr 2026 | 6482.62 | 6420.97 to 6483.63 | 0.2% | 0 times |
| 01 Wed Apr 2026 | 6469.72 | 6457.34 to 6487.89 | -0.09% | 0 times |
| 31 Tue Mar 2026 | 6475.36 | 6388.18 to 6475.38 | 1.74% | 0 times |
| 30 Mon Mar 2026 | 6364.74 | 6343.23 to 6447.92 | -0.44% | 0 times |
| 27 Fri Mar 2026 | 6392.97 | 6382.46 to 6453.41 | -0.76% | 0 times |
| 26 Thu Mar 2026 | 6442.22 | 6438.61 to 6509.59 | -1.02% | 0 times |
| 25 Wed Mar 2026 | 6508.86 | 6486.56 to 6537.73 | 0.34% | 0 times |
| 24 Tue Mar 2026 | 6486.56 | 6447.95 to 6533.13 | 0.2% | 0 times |
| 23 Mon Mar 2026 | 6473.59 | 6454.78 to 6523.47 | -1.79% | 0 times |
| 17 Tue Mar 2026 | 6591.69 | 6586.44 to 6629.57 | 0.08% | 0 times |
Videos related to: SBNP announcements S&p Custom/bnp Paribas Spectrumus Sect announcements and dividends declared INDICES
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- INDICES Screeners
- INDICES Daily Screener
- INDICES Weekly Screener
- INDICES Monthly Screener
- Support & Resistance
- INDICES Shares Near Support
- INDICES Shares Near Resistance


